The Plk1 Inhibitor BI 2536 Temporarily Arrests Primary Cardiac Fibroblasts in Mitosis and Generates Aneuploidy In Vitro

BI 2536 is a new anti-mitotic drug that targets polo-like kinase 1 (Plk1) and is currently under clinical development for cancer therapy. The effect of this drug on cancer cells has been extensively investigated, but information about the effects on primary dividing cells and differentiated non-divi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Lu, Bo, Mahmud, Hasan, Maass, Alexander H., Yu, Bo, van Gilst, Wiek H., de Boer, Rudolf A., Silljé, Herman H. W.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2010
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2945759/
https://ncbi.nlm.nih.gov/pubmed/20886032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0012963
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items